Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Aug 27, 2010


Joseph Nadeau this week was appointed to the newly created position of director of research and academic affairs at the Institute of Systems Biology.

Previously he was the James H. Jewel professor and chair of the genetics department at the Case Western Reserve School of Medicine where his research focused on discoveries in experimental models of human diseases such as cancers and obesity. He has also been a longtime ISB collaborator.

Caris Life Sciences this week named Winston Lam executive vice president of business development and chief legal officer.

Previously Lam was group vice president and associate general counsel for the global pharmaceutical business at Schering-Plough. Prior to that, he led business development functions at McKesson and Baxter Healthcare.

Agilent last week gave Thomas Hartung, director of Johns Hopkins Center for Alternatives to Animal Testing, an Agilent Thought Leader Award for his research into using toxicity pathways to predict developmental neurotoxicity.

Hartung's work "could help identify possible contributions of chemicals to disorders such as autism and attention hyperactivity disorders," Agilent said. The award includes funding and a donation of instruments worth more than $500,000.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.